Medicare Enrolled
Dr. Joseph Ye, MD, PHD
Medical Oncology · Olympia, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ye from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ye?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ye
Dr. Joseph Ye is a medical oncology specialist in Olympia, WA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ye performed 217,452 Medicare services across 4,312 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ye received a total of $127,885 from 117 pharmaceutical and/or device companies across 1525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ye is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 1% volume in WA
$127,885 industry payments
Medicare Practice Summary
Medicare Utilization ↗217,452
Medicare services
Top 1% in WA for medical oncology
4,312
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10,355 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nivolumab injection (Opdivo) | 23,520 | $24 | $88 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
22,950 | $0 | $4 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
22,300 | $0 | $18 |
| Pembrolizumab injection (Keytruda) | 18,600 | $43 | $157 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
17,300 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 16,260 | $19 | $64 |
| Filgrastim-ayow biosimilar injection, 1 microgram An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram. |
14,700 | $0 | $2 |
| Filgrastim injection, 1 microgram An injection of filgrastim, a medication that stimulates the production of white blood cells. This code specifically covers the brand-name drug and excludes biosimilar versions. |
11,880 | $1 | $3 |
| Anti-nausea injection (aprepitant) | 9,950 | $1 | $6 |
| Paclitaxel protein-bound particle injection An injection of paclitaxel formulated as protein-bound particles. This code specifies the administration of the medication measured in milligrams. |
9,710 | $10 | $43 |
| Paclitaxel chemotherapy injection | 8,701 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,842 | $0 | $1 |
| Injection, docetaxel, 1 mg | 4,624 | $1 | $7 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
3,787 | $22 | $170 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,300 | $6 | $25 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,046 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,040 | $1 | $41 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,965 | $8 | $9 |
| Iron infusion (Monoferric) | 1,900 | $16 | $74 |
| Injection, fulvestrant, 25 mg | 1,890 | $8 | $139 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,772 | $95 | $390 |
| Anti-nausea injection (ondansetron/Zofran) | 1,454 | $0 | $3 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
1,024 | $1 | $2 |
| Injection, potassium chloride, per 2 meq | 860 | $0 | $4 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
805 | $2 | $7 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
772 | $12 | $66 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
715 | $103 | $421 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
649 | $11 | $67 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
549 | $2 | $39 |
| Injection, leucovorin calcium, per 50 mg | 532 | $3 | $14 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
512 | $22 | $103 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
442 | $1 | $4 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 421 | $3 | $42 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
359 | $50 | $208 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
348 | $51 | $205 |
| Pegfilgrastim-apgf injection An injection of pegfilgrastim-apgf, a biosimilar medication. The dose specified is 0.5 mg. |
336 | $84 | $654 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
333 | $69 | $210 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
325 | $22 | $164 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
276 | $138 | $550 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
266 | $26 | $135 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
219 | $1 | $6 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
206 | $57 | $234 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
204 | $2 | $9 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
194 | $16 | $65 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 176 | $133 | $603 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
155 | $93 | $308 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
140 | $3 | $13 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
115 | $66 | $277 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
104 | $6 | $126 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
93 | $1 | $20 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
90 | $43 | $177 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
87 | $10 | $40 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
68 | $15 | $63 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
66 | $44 | $180 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
63 | $10 | $39 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
61 | $137 | $613 |
| New patient office visit, complex (60-74 min) | 50 | $167 | $673 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
49 | $4 | $12 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $136 | $595 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
44 | $1 | $6 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
29 | $30 | $121 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
27 | $17 | $83 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
25 | $3 | $11 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
24 | $6 | $19 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
22 | $26 | $105 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
21 | $110 | $509 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
17 | $13 | $41 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
17 | $1 | $17 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
14 | $141 | $543 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
11 | $15 | $46 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.6% high complexity
84.0% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$127,885
Total received (2018-2024)
Avg $18,269/year across 7 years
Top 5% in WA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
117
Companies
1,525
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$84,620 (66.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,134 (19.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,131 (14.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$14,045
2023
$20,385
2022
$27,377
2021
$8,789
2020
$8,922
2019
$21,604
2018
$26,763
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ipsen Biopharmaceuticals, Inc
$3,196
Astellas Pharma Global Development
$2,172
Karyopharm Therapeutics Inc.
$1,692
AstraZeneca Pharmaceuticals LP
$1,360
PFIZER INC.
$1,282
GENZYME CORPORATION
$995
ABBVIE INC.
$455
Astellas Pharma US Inc
$276
Merck Sharp & Dohme LLC
$192
Novartis Pharmaceuticals Corporation
$182
Celgene Corporation
$178
E.R. Squibb & Sons, L.L.C.
$169
Incyte Corporation
$167
GlaxoSmithKline, LLC.
$151
Janssen Biotech, Inc.
$104
TAIHO ONCOLOGY, INC.
$104
BeiGene USA, Inc.
$99
Genentech USA, Inc.
$97
Genmab U.S., Inc.
$96
Dendreon Pharmaceuticals LLC
$95
Tempus AI, Inc
$91
Bayer Healthcare Pharmaceuticals Inc.
$75
Lilly USA, LLC
$68
Exelixis Inc.
$59
ARRAY BIOPHARMA INC
$55
Stemline Therapeutics Inc.
$55
Mirati Therapeutics, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$51
Coherus Biosciences Inc.
$50
Deciphera Pharmaceuticals Inc.
$48
Daiichi Sankyo Inc.
$43
ADC Therapeutics America, Inc.
$38
Apellis Pharmaceuticals, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$26
TerSera Therapeutics LLC
$25
ACCORD HEALTHCARE, INC.
$23
Janssen Pharmaceuticals, Inc
$22
Sumitomo Pharma America, Inc.
$21
Agios Pharmaceuticals, Inc.
$21
Gilead Sciences, Inc.
$21
Pharmacosmos Therapeutics Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$18
Blueprint Medicines Corporation
$18
Azurity Pharmaceuticals, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
SERVIER PHARMACEUTICALS LLC
$14
Top 3 companies account for 50.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$21,273
Genentech USA, Inc.
$10,730
Celgene Corporation
$8,108
Karyopharm Therapeutics Inc.
$6,514
Kite Pharma, Inc.
$6,280
Rigel Pharmaceuticals, Inc.
$5,791
Astellas Pharma Global Development
$5,662
Genentech, Inc.
$5,616
Lilly USA, LLC
$5,065
AbbVie, Inc.
$4,639
TESARO, Inc.
$3,618
Ipsen Biopharmaceuticals, Inc
$3,459
Novartis Pharmaceuticals Corporation
$3,377
JAZZ PHARMACEUTICALS INC.
$3,276
Daiichi Sankyo Inc.
$2,756
PFIZER INC.
$2,203
E.R. Squibb & Sons, L.L.C.
$2,198
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,069
Astellas Pharma US Inc
$1,942
Exelixis Inc.
$1,753
MorphoSys, US Inc.
$1,554
GENZYME CORPORATION
$1,534
G1 Therapeutics, Inc.
$1,521
Amgen Inc.
$1,387
Seagen Inc.
$1,146
Pharmacyclics LLC, An AbbVie Company
$956
AbbVie Inc.
$909
Incyte Corporation
$897
Foundation Medicine, Inc.
$782
Bayer HealthCare Pharmaceuticals Inc.
$707
Janssen Biotech, Inc.
$691
ABBVIE INC.
$600
Merck Sharp & Dohme LLC
$535
Merck Sharp & Dohme Corporation
$496
Clovis Oncology, Inc.
$368
GlaxoSmithKline, LLC.
$344
Seattle Genetics, Inc.
$336
Eisai Inc.
$329
Regeneron Healthcare Solutions, Inc.
$281
BeiGene USA, Inc.
$276
Dendreon Pharmaceuticals LLC
$243
Agios Pharmaceuticals, Inc.
$218
Pharmacyclics LLC, an AbbVie Company
$198
Coherus Biosciences Inc.
$197
TerSera Therapeutics LLC
$193
SOBI, INC
$188
Puma Biotechnology, Inc.
$187
Takeda Pharmaceuticals U.S.A., Inc.
$180
Taiho Oncology, Inc.
$168
ARRAY BIOPHARMA INC
$159
EISAI INC.
$151
Deciphera Pharmaceuticals Inc.
$150
AVEO Pharmaceuticals, Inc.
$140
Aurobindo Pharma USA, Inc.
$137
Genmab U.S., Inc.
$127
Spectrum Pharmaceuticals Inc.
$125
EMD Serono, Inc.
$125
Stemline Therapeutics Inc.
$122
Myovant Sciences Inc.
$113
Aveo Pharmaceuticals, Inc.
$113
Mirati Therapeutics, Inc.
$105
TAIHO ONCOLOGY, INC.
$104
Apellis Pharmaceuticals, Inc.
$101
Bayer Healthcare Pharmaceuticals Inc.
$100
Helsinn Therapeutics (U.S.), Inc.
$99
Gilead Sciences, Inc.
$98
Janssen Pharmaceuticals, Inc
$95
Tempus AI, Inc
$91
Dova Pharmaceuticals
$91
Novocure Inc.
$86
SANOFI-AVENTIS U.S. LLC
$86
Alexion Pharmaceuticals, Inc.
$80
Janssen Scientific Affairs, LLC
$78
Blueprint Medicines Corporation
$76
Janssen Products, LP
$75
Epizyme, Inc.,
$74
ADC Therapeutics America, Inc.
$72
GE HEALTHCARE
$60
Heron Therapeutics, Inc.
$57
Sun Pharmaceutical Industries Inc.
$55
TG Therapeutics, Inc.
$54
EUSA Pharma (US) LLC
$53
PUMA BIOTECHNOLOGY, INC.
$49
CTI BioPharma Corp.
$46
Sumitomo Pharma America, Inc.
$40
ACCORD HEALTHCARE, INC.
$40
Pharmacosmos Therapeutics Inc.
$38
SERVIER PHARMACEUTICALS LLC
$38
Sirtex Medical Inc
$37
Horizon Therapeutics plc
$37
Mylan Institutional Inc.
$37
PORTOLA PHARMACEUTICALS, INC.
$35
United Therapeutics Corporation
$32
INSYS Therapeutics Inc
$32
Sobi, Inc
$31
Lexicon Pharmaceuticals, Inc.
$31
TG THERAPEUTICS, INC.
$28
Jazz Pharmaceuticals Inc.
$28
Myriad Genetic Laboratories, Inc.
$26
Roche Diagnostics Corporation
$24
GE HealthCare
$20
Octapharma USA, Inc.
$20
Kyowa Kirin, Inc.
$20
Acrotech Biopharma Inc.
$19
Adaptive Biotechnologies Corporation
$18
Midatech Pharma US Inc
$17
Innate Pharma, Inc
$17
Azurity Pharmaceuticals, Inc.
$16
Otsuka America Pharmaceutical, Inc.
$16
Horizon Pharma plc
$15
Pharming Healthcare, Inc.
$14
AMAG Pharmaceuticals, Inc.
$14
Acceleron Pharma, Inc.
$12
BTG International, Inc.
$11
ADMA BioManufacturing LLC
$10
Secura Bio, Inc.
$10
Emmaus Medical, Inc.
$7
Top 3 companies account for 31.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BEVYXXA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · CABOMETYX · CALQUENCE · CAMCEVI · CHANTIX · COSELA · CRESEMBA · CYRAMZA · Cabometyx · Cinvanti · Columvi · DARZALEX · DIS Navify Software · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GAVRETO · GAZYVA · GILOTRIF · Gelclair · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INFUGEM · INJECTAFER · INLYTA · INQOVI · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lunsumio · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · MOVANTIK · MVASI · NERLYNX · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORENCIA · ORENITRAM · ORGOVYX · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · REZUROCK · ROLVEDON · RUCONEST · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUBSYS · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TRUSELTIQ · TUKYSA · Tavalisse · Tibsovo · Trodelvy · Turalio · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VORAXAZE · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XERMELO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YERVOY · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · ZYTIGA · Zoladex · Zydelig · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (66%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for medical oncology in WA.
Geographic Context
Medical oncologists within 10 mi
5
Per 100K population
1.7
County median income
$93,985
Nearest hospital
CAPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ye is a mixed practice specialist, with above-average Medicare volume (top 1% in WA), with consulting-driven industry engagement in the top 5% of WA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ye experienced with nivolumab injection (opdivo)?
Based on Medicare claims data, Dr. Ye performed 23,520 nivolumab injection (opdivo) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ye receive payments from pharmaceutical companies?
Yes. Dr. Ye received a total of $127,885 from 117 companies across 1,525 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ye's costs compare to other medical oncologists in Olympia?
Dr. Ye's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ye) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Olympia
Browse medical oncologists in Olympia ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in WA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in WA
Which WA medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology